Jardiance (empagliflozin)

pCPA File Number: 20956
Negotiation Status:
Concluded with an LOI
Indication(s):
Diabetes Mellitus, Type 2 with high cardiovascular risk
Sponsor/Manufacturer:
Boehringer Ingelheim (Canada) Ltd. Ltee.
CADTH Project Number:
SR0488-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: